1. Beyond cabazitaxel: Late line treatments in metastatic castration resistant prostate cancer: A retrospective multicentre analysis. Issue 6 (30th January 2022) Authors: Chazan, Grace; Anton, Angelyn; Wong, Shirley; Shapiro, Julia; Weickhardt, Andrew; Azad, Arun; Kwan, Edmond M; Spain, Lavinia; Gunjur, Ashray; Torres, Javier; Parente, Phillip; Parnis, Francis; Goh, Jeffrey; Gibbs, Peter; Tran, Ben Journal: Asia-Pacific journal of clinical oncology Issue: Volume 18:Issue 6(2022) Page Start: 642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cancer clinical trial vs real‐world outcomes for standard of care first‐line treatment in the advanced disease setting. Issue 2 (13th April 2021) Authors: Kostos, Louise; Hong, Wei; Lee, Belinda; Tran, Ben; Lok, Sheau Wen; Anton, Angelyn; Gard, Grace; To, Yat Hang; Wong, Vanessa; Shapiro, Jeremy; Wong, Rachel; Wong, Shirley; de Boer, Richard; Gibbs, Peter Journal: International journal of cancer Issue: Volume 149:Issue 2(2021) Page Start: 409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Global Disparity in Access to Novel Therapeutics for Metastatic Prostate Cancer. Issue 1 (January 2022) Authors: Anton, Angelyn; Tran, Ben Journal: JCO oncology practice Issue: Volume 18:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Impact of access to novel therapies on the initial management of castrate‐resistant prostate cancer: an Australian multicentre study. Issue 11 (11th November 2019) Authors: Kwan, Edmond M.; Semira, Marie C.; Bergin, Alice R. T.; Muttiah, Christine; Beck, Sophie; Anton, Angelyn; Campbell, David; Wong, Shirley; Rosenthal, Mark; Gibbs, Peter; Tran, Ben Journal: Internal medicine journal Issue: Volume 49:Issue 11(2019) Page Start: 1378 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Molecular classification of hormone‐sensitive and castration‐resistant prostate cancer, using nonnegative matrix factorization molecular subtyping of primary and metastatic specimens. Issue 9 (18th April 2022) Authors: Yuen, Kobe C.; Tran, Ben; Anton, Angelyn; Hamidi, Habib; Costello, Anthony J.; Corcoran, Niall M.; Lawrentschuk, Nathan; Rainey, Natalie; Semira, Marie C. G.; Gibbs, Peter; Mariathasan, Sanjeev; Sandhu, Shahneen; Kadel, Edward E. Journal: Prostate Issue: Volume 82:Issue 9(2022) Page Start: 993 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Prostate‐specific membrane antigen positron emission tomography‐computed tomography use prior to systemic therapy in metastatic castration‐resistant prostate cancer. (30th November 2022) Authors: Kelly, Richard; Jensen, Andrew; Karunaratna, Nathasha; Wong, Shirley; Shapiro, Julia; Weickhardt, Andrew; Parente, Phillip; Azad, Arun A.; Uccellini, Anthony; Torres, Javier; Parnis, Francis; Goh, Jeffrey; Kwan, Edmond M.; Brown, Stephen; Steer, Christopher; Warren, Mark; Gibbs, Peter; Tran, Ben;... Journal: BJU international Issue: Volume 131:Number 2(2023) Page Start: 179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter?. (7th February 2023) Authors: Pereira-Salgado, Amanda; Anton, Angelyn; Franchini, Fanny; Mahar, Robert K.; Kwan, Edmond M.; Wong, Shirley; Shapiro, Julia; Weickhardt, Andrew; Azad, Arun A.; Spain, Lavinia; Gunjur, Ashray; Torres, Javier; Parente, Phillip; Parnis, Francis; Goh, Jeffrey; Steer, Christopher; Brown, Stephen; Gibb... Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 23:Number 2(2023) Page Start: 231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Real-world incidence of symptomatic skeletal events and bone-modifying agent use in castration-resistant prostate cancer – an Australian multi-centre observational study. (November 2021) Authors: Anton, Angelyn; Wong, Shirley; Shapiro, Julia; Weickhardt, Andrew; Azad, Arun; Kwan, Edmond M.; Spain, Lavinia; Gunjur, Ashray; Torres, Javier; Parente, Phillip; Parnis, Francis; Goh, Jeffrey; Semira, Marie C.; Gibbs, Peter; Tran, Ben; Pezaro, Carmel Journal: European journal of cancer Issue: Volume 157(2021) Page Start: 485 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Real‐world first‐line systemic therapy patterns in metastatic castration‐resistant prostate cancer. Issue 3 (14th December 2021) Authors: Anton, Angelyn; Pillai, Sruti; Semira, Marie Christine; Wong, Shirley; Shapiro, Julia; Weickhardt, Andrew; Azad, Arun; Kwan, Edmond M.; Spain, Lavinia; Gunjur, Ashray; Torres, Javier; Parente, Phillip; Parnis, Francis; Goh, Jeffrey; Baenziger, Olivia; Gibbs, Peter; Tran, Ben Journal: BJUI Compass Issue: Volume 3:Issue 3(2022) Page Start: 205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Real‐world use of first‐generation antiandrogens: impact on patient outcomes and subsequent therapies in metastatic castration‐resistant prostate cancer. Issue Volume 128:Issue Supplement 1(2021) (7th October 2021) Authors: Kelly, Richard; Anton, Angelyn; Wong, Shirley; Shapiro, Julia; Weickhardt, Andrew; Azad, Arun; Kwan, Edmond Michael; Spain, Lavinia; Muthusamy, Arun; Torres, Javier; Parente, Phillip; Parnis, Francis; Goh, Jeffrey; Joshua, Anthony; Pook, David; Baenziger, Olivia; Gibbs, Peter; Tran, Ben Journal: BJU international Issue: Volume 128:Issue Supplement 1(2021) Page Start: 18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗